Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Asciminib (Scemblix) market share over 30% in US by end of 2025?  | Binary | 3 | 2 months ago | ||
Asciminib (Scemblix) major molecular response rate by end of 2025? | Categorical | 3 | 2 months ago | ||
Health Canada approval for Asciminib (Scemblix) by March 31, 2025? | Binary | 2 | 2 months ago | ||
Major adverse effects reported for Asciminib (Scemblix) in US by October 2025? | Binary | 2 | 2 months ago | ||
Next region to approve Asciminib (Scemblix) after US by end of 2025? | Categorical | 2 | 2 months ago | ||
Main competitor to Asciminib (Scemblix) in US by end of 2025? | Categorical | 2 | 2 months ago |